Ceylon Hospitals PLC (COSE: CHL.X0000)
94.00
0.00 (0.00%)
At close: Sep 9, 2024
Ceylon Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Revenue | 9,189 | 9,153 | 7,905 | 7,841 | 5,546 | 5,976 | Upgrade
|
Revenue Growth (YoY) | 8.60% | 15.78% | 0.82% | 41.39% | -7.20% | 2.92% | Upgrade
|
Cost of Revenue | 3,969 | 4,014 | 3,095 | 2,880 | 2,052 | 2,124 | Upgrade
|
Gross Profit | 5,219 | 5,139 | 4,811 | 4,961 | 3,494 | 3,852 | Upgrade
|
Selling, General & Admin | 3,377 | 3,302 | 2,878 | 2,854 | 2,337 | 2,677 | Upgrade
|
Other Operating Expenses | 1,236 | 1,254 | 1,020 | 717.5 | 521.87 | 529.07 | Upgrade
|
Operating Expenses | 4,613 | 4,556 | 3,898 | 3,571 | 2,859 | 3,206 | Upgrade
|
Operating Income | 606.41 | 582.91 | 913.18 | 1,389 | 634.5 | 645.71 | Upgrade
|
Interest Expense | -181.32 | -144.05 | -83.35 | -76.56 | -93.01 | -138.53 | Upgrade
|
Interest & Investment Income | 89.62 | 99.66 | 207.25 | 81.82 | 50.31 | 70.79 | Upgrade
|
Earnings From Equity Investments | - | - | - | 11.72 | 102.87 | 1.01 | Upgrade
|
Other Non Operating Income (Expenses) | -0.62 | -0.62 | -4.54 | -4.01 | -3.67 | -2.2 | Upgrade
|
EBT Excluding Unusual Items | 514.09 | 537.9 | 1,033 | 1,402 | 691 | 576.78 | Upgrade
|
Gain (Loss) on Sale of Investments | 113.44 | 113.44 | 27.8 | -32.92 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 6.43 | 6.43 | - | 5.2 | 5.34 | -1.12 | Upgrade
|
Other Unusual Items | 1.11 | 1.11 | - | 14.45 | - | - | Upgrade
|
Pretax Income | 635.08 | 658.89 | 1,060 | 1,389 | 696.34 | 575.66 | Upgrade
|
Income Tax Expense | 179.34 | 205.07 | 408.65 | 279.38 | 96.08 | 108.57 | Upgrade
|
Earnings From Continuing Operations | 455.73 | 453.81 | 651.67 | 1,110 | 600.26 | 467.09 | Upgrade
|
Minority Interest in Earnings | -36.33 | -36.62 | -79.84 | -127.2 | -39.91 | -63.82 | Upgrade
|
Net Income | 419.41 | 417.19 | 571.83 | 982.32 | 560.35 | 403.27 | Upgrade
|
Net Income to Common | 419.41 | 417.19 | 571.83 | 982.32 | 560.35 | 403.27 | Upgrade
|
Net Income Growth | 3.06% | -27.04% | -41.79% | 75.31% | 38.95% | 25.33% | Upgrade
|
Shares Outstanding (Basic) | 36 | 36 | 34 | 34 | 34 | 34 | Upgrade
|
Shares Outstanding (Diluted) | 36 | 36 | 34 | 34 | 34 | 34 | Upgrade
|
Shares Change (YoY) | 3.84% | 6.23% | 0.02% | - | - | - | Upgrade
|
EPS (Basic) | 11.74 | 11.59 | 16.88 | 29.00 | 16.54 | 11.91 | Upgrade
|
EPS (Diluted) | 11.74 | 11.59 | 16.88 | 29.00 | 16.54 | 11.91 | Upgrade
|
EPS Growth | -0.75% | -31.32% | -41.80% | 75.31% | 38.95% | 25.33% | Upgrade
|
Free Cash Flow | 195.89 | -60.01 | -2,110 | 395.27 | 879.95 | -72.27 | Upgrade
|
Free Cash Flow Per Share | 5.48 | -1.67 | -62.29 | 11.67 | 25.98 | -2.13 | Upgrade
|
Dividend Per Share | 2.000 | 2.000 | 2.300 | 5.000 | 3.200 | 2.200 | Upgrade
|
Dividend Growth | -13.04% | -13.04% | -54.00% | 56.25% | 45.45% | -50.67% | Upgrade
|
Gross Margin | 56.80% | 56.14% | 60.85% | 63.27% | 63.00% | 64.46% | Upgrade
|
Operating Margin | 6.60% | 6.37% | 11.55% | 17.72% | 11.44% | 10.81% | Upgrade
|
Profit Margin | 4.56% | 4.56% | 7.23% | 12.53% | 10.10% | 6.75% | Upgrade
|
Free Cash Flow Margin | 2.13% | -0.66% | -26.70% | 5.04% | 15.87% | -1.21% | Upgrade
|
EBITDA | 1,077 | 1,025 | 1,302 | 1,729 | 989.24 | 1,077 | Upgrade
|
EBITDA Margin | 11.72% | 11.20% | 16.48% | 22.05% | 17.84% | 18.02% | Upgrade
|
D&A For EBITDA | 470.68 | 442.58 | 389.26 | 339.85 | 354.74 | 431.33 | Upgrade
|
EBIT | 606.41 | 582.91 | 913.18 | 1,389 | 634.5 | 645.71 | Upgrade
|
EBIT Margin | 6.60% | 6.37% | 11.55% | 17.72% | 11.44% | 10.81% | Upgrade
|
Effective Tax Rate | 28.24% | 31.12% | 38.54% | 20.12% | 13.80% | 18.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.